Silence Therapeutics (SLN) Operating Leases (2023 - 2026)

Silence Therapeutics has disclosed Operating Leases across 3 years of filings, most recently posting $43000.0 for Q1 2026.

• Operating Leases for Q1 2026 came in at $43000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $43000.0 (changed N/A YoY), and the FY2025 annual result was $71000.0, changed N/A from the prior year.
• Operating Leases came in at $43000.0 for Q1 2026 at Silence Therapeutics, down from $71000.0 in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $115427.1 in Q4 2023 to a low of $43000.0 in Q1 2026.
• The 3-year median for Operating Leases is $84000.0 (2025), against an average of $81606.8.